805
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Effect of emulsification-diffusion parameters on the formation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate) particles

&
Pages 226-234 | Received 20 May 2014, Accepted 19 Jun 2014, Published online: 24 Jul 2014

References

  • Astete CE, Sabliov CM. 2006. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed. 17:247–289.
  • Baran ET, Özer N, Hasirci V. 2002. Poly(hydroxybutyrate-co-hydroxyvalerate) nanocapsules as enzyme carriers for cancer therapy: an in vitro study. J Microencapsulation. 19:363–376.
  • Bilati U, Alleman E, Doelker E. 2005. Development of a nanoprecipitaion method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci. 24:67–75.
  • Budhian A, Siegel S, Winey K. 2007. Haloperidol-loaded PLGA nanoparticles: systemic study of particle size and drug content. Int J Pharm. 336:367–375.
  • Chaisri W, Hennink WE, Okonogi S. 2009. Preparation and characterization of cephalexin loaded PLGA microspheres. Curr Drug Deliv. 6:69–75.
  • Chaudhari A, Vanmellart L, Bauwens M, Vermaelen P, Deroose CM, Naert I, et al. 2013. In vitro and in vivo investigation of the potential of amorphous micro porous silica as a protein delivery vehicle. BioMed Res Int. 2013:10.
  • Cheow WS, Hadinoto K. 2010. Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolid acid) nanoparticles: Modifications of standard nanoparticle preparation methods. Colloids Surf A. 370:79–86.
  • Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, et al. 2011. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Eur J Pharm Biopaharm. 77:26–35.
  • Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F. 2011. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine. 6:877–895.
  • Esmaeili F, Atyabi F, Dinarvand R. 2008. Preparation and characterization of estradiol-loaded PLGA nanoparticles using homogenization-solvent diffusion method. DARU. 26:196–202.
  • Estey T, Kang J, Schwendeman P, Carpenter J. 2006. BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. J Pharm Sci. 95:1626–1639.
  • Gasparini G, Kosvintsev SR, Stillwell MT, Holdich RG. 2008. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification. Colloids Surf B Biointerfaces. 61:199–207.
  • Jaklenec A, Hinckfuss A, Bilgen B, Ciombor DM, Aoron R, Mathiowits E. 2008. Sequential release of bioactive IGF-I and TGF-β1 from PLGA microsphere-based scaffolds. Biomaterials. 29:1518–1525.
  • Kowalczuk A, Trzcinska R, Trzebicka B, Müller AHE, Dworak A, Tsvetanov CB. 2014. Loading of polymer nanocarriers: Factors, mechanisms and applications. Prog Poly Sci. 39:43–86.
  • Kwon H, Lee J, Choi S, Jang Y, Kim J. 2001. Preperation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf A. 182:123–130.
  • Lao LL, Peppas NA, Boey FYC, Venkatraman SS. 2011. Modeling drug release from bulk-degrading polymers. Int J Pharm. 418:28–41.
  • Masood F, Chen P, Yasin T, Fatima N, Hasan F, Hameed A. 2013. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application. Mater Sci Eng C Mater Biol Appl. 33:1054–1060.
  • Mainardes R, Evangelista R. 2005. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 290:137–144.
  • Palamoor M, Jablonski MM. 2014. Comparative study on diffusion and evaporation emulsion methods used to load hydrophilic drugs in poly(ortho ester) nanoparticle emulsions. Powder Technol. 253:53–62.
  • Pich A, Schiemenz N, Corten C, Adler HJP. 2006. Thermoreversible gelation of biodegradable polyester (PHBV) in toluen. Polymer. 47:1912–1920.
  • Poletto FS, Fiel L, Donida B, Re M. 2008. Controlling the size of PHBV nanoparticles prepared by emulsification-diffusion technique using ethanol as surfactant agent. Colloids Surf A. 324:105–112.
  • Pulat M, Ekmekçi A, Aslim B. 2006. The release of bovine serum albumin from polyurethane based hydrophilic and hydrophobic disks and microbiological interactions. Bio-Med Mater Eng. 16: 147–156.
  • Sahana DK, Mıttal G, Bhardwaj V, Ravi Kumar MN. 2008. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using Estradiol as a model drug. J Pharm Sci. 97:1530–1542.
  • Song X, Zhao Y, Hou S, Xu F, Zhao R, He J, et al. 2008. Dual agents loaded PLGA nanoparticles: Systemic study of particle size and drug entrapment efficiency. Eur J Pharm Biopaharm. 69:445–453.
  • Teng L, Jiang C, Lin X, Dong Y, Li C, Meng Q, Li Y. 2010. Preperation of tolterodine metabolite loaded biodegradable PLGA microspheres. Chem Res Univ. 26:75–80.
  • Vilos C, Morales FA, Solar PA, Herrera NS, Gonzalez-Nilo FD, Aguayo DA, et al. 2013. Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells. Biomaterials. 34:4098–4108.
  • Vroman I, Tighzert L. 2009. Biodegradable polymers. Materials. 2:307–344.
  • Yilgor P, Hasirci N, Hasirci V. 2010. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res A. 93: 528–536.
  • Vo TN, Kasper FK, Mikos AG. 2012. Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev. 64:1292–1309.
  • Yeo Y, Park K. 2004. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res. 27:1–12.
  • Weast RC. 1974. Handbook of Chemistry and Physics. Boca Raton, FL: CRC Press Inc.
  • Zhu XH, Wang C, Tong YW. 2009. In-vitro characteriztion of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. J Biomed Mater Res Part A. 89:411–429.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.